title: Reply: To PMID 25201241.
authors.affiliation: University of Alabama at Birmingham.
authors.forename: Huifeng
authors.initials: H
authors.lastname: Yun
authors.affiliation: University of Alabama at Birmingham.
authors.forename: John W
authors.initials: JW
authors.lastname: Badley
authors.affiliation: University of Alabama at Birmingham.
authors.forename: Jeffrey R
authors.initials: JR
authors.lastname: Curtis
authors.affiliation: Oregon Health and Science University, Portland.
authors.forename: Kevin
authors.initials: K
authors.lastname: Winthrop
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001688:Biological Products / Q000009:adverse effects*; D005260:Female; D006562:Herpes Zoster / Q000453:epidemiology*; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000453:epidemiology*
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products